IDEXX Announces UK Availability of Cancer Dx Panel for Early Detection of Canine Lymphoma [Yahoo! Finance]
IDEXX Announces UK Availability of Cancer Dx Panel for Early Detection of Canine Lymphoma
IDEXX Laboratories (IDXX) had its price target lowered by Stifel Nicolaus from $775.00 to $675.00. They now have a "buy" rating on the stock.
Pet Services Jump 5.1% as Vet Visits Fall for 16th Straight Quarter [Yahoo! Finance]
Why pet owners are cutting vet visits but still paying $11,000 for surgeries [Los Angeles Times (CA)]